Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

A Population-Based Study of Morbidity After Pancreatic Cancer Diagnosis.

Sarkar RR, Fero KE, Seible DM, Panjwani N, Matsuno RK, Murphy JD.

J Natl Compr Canc Netw. 2019 May 1;17(5):432-440. doi: 10.6004/jnccn.2018.7111.

PMID:
31085756
2.

Clinical Impact of Local Progression in Pancreatic Cancer.

Cardillo N, Seible DM, Fero KE, Bruggeman AR, Sarkar RR, Azuara A, Simpson DR, Murphy JD.

J Natl Compr Canc Netw. 2018 Jun;16(6):711-717. doi: 10.6004/jnccn.2018.7013.

PMID:
29891522
3.

Primary advanced unresectable pancreatic cancer.

Wilkowski R, Wolf M, Heinemann V.

Recent Results Cancer Res. 2008;177:79-93. Review.

PMID:
18084950
4.

Image-guided stereotactic radiosurgery for locally advanced pancreatic adenocarcinoma results of first 85 patients.

Didolkar MS, Coleman CW, Brenner MJ, Chu KU, Olexa N, Stanwyck E, Yu A, Neerchal N, Rabinowitz S.

J Gastrointest Surg. 2010 Oct;14(10):1547-59. doi: 10.1007/s11605-010-1323-7. Epub 2010 Sep 14.

PMID:
20839073
5.

Five-Fraction Stereotactic Body Radiation Therapy (SBRT) and Chemotherapy for the Local Management of Metastatic Pancreatic Cancer.

Lischalk JW, Burke A, Chew J, Elledge C, Gurka M, Marshall J, Pishvaian M, Collins S, Unger K.

J Gastrointest Cancer. 2018 Jun;49(2):116-123. doi: 10.1007/s12029-016-9909-2.

PMID:
28044263
6.

Costs and trends in pancreatic cancer treatment.

O'Neill CB, Atoria CL, O'Reilly EM, LaFemina J, Henman MC, Elkin EB.

Cancer. 2012 Oct 15;118(20):5132-9. doi: 10.1002/cncr.27490. Epub 2012 Mar 13.

7.

Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.

Coia L, Hoffman J, Scher R, Weese J, Solin L, Weiner L, Eisenberg B, Paul A, Hanks G.

Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):161-7.

PMID:
8083109
8.

National trends in pancreatic cancer outcomes and pattern of care among Medicare beneficiaries, 2000 through 2010.

Wang Y, Schrag D, Brooks GA, Dominici F.

Cancer. 2014 Apr 1;120(7):1050-8. doi: 10.1002/cncr.28537. Epub 2013 Dec 30.

9.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
10.

Feasibility study of the treatment of primary unresectable carcinoma of the pancreas with 103Pd brachytherapy.

Raben A, Mychalczak B, Brennan MF, Minsky B, Anderson L, Casper ES, Harrison LB.

Int J Radiat Oncol Biol Phys. 1996 May 1;35(2):351-6.

PMID:
8635943
11.
12.

Cachexia worsens prognosis in patients with resectable pancreatic cancer.

Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME.

J Gastrointest Surg. 2008 Jul;12(7):1193-201. doi: 10.1007/s11605-008-0505-z. Epub 2008 Mar 18.

PMID:
18347879
13.

Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer.

Aristu J, Cañón R, Pardo F, Martínez-Monge R, Martin-Algarra S, Manuel Ordoñez J, Villafranca E, Moreno M, Cambeiro M, Azinovic I.

Am J Clin Oncol. 2003 Feb;26(1):30-6.

PMID:
12576921
14.

Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer.

Wanebo HJ, Glicksman AS, Vezeridis MP, Clark J, Tibbetts L, Koness RJ, Levy A.

Arch Surg. 2000 Jan;135(1):81-7; discussion 88.

PMID:
10636353
15.

Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.

Canto MI, Almario JA, Schulick RD, Yeo CJ, Klein A, Blackford A, Shin EJ, Sanyal A, Yenokyan G, Lennon AM, Kamel IR, Fishman EK, Wolfgang C, Weiss M, Hruban RH, Goggins M.

Gastroenterology. 2018 Sep;155(3):740-751.e2. doi: 10.1053/j.gastro.2018.05.035. Epub 2018 May 24.

PMID:
29803839
16.

Medical Error Prevention.

Rodziewicz TL, Hipskind JE.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 May 5.

18.

A phase I trial of intravenous bromodeoxyuridine and radiation therapy for pancreatic cancer.

Robertson JM, Ensminger WD, Walker S, Lawrence TS.

Int J Radiat Oncol Biol Phys. 1997 Jan 15;37(2):331-5.

PMID:
9069304
19.

Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study.

Smyth EN, Bapat B, Ball DE, André T, Kaye JA.

Clin Ther. 2015 Jun 1;37(6):1301-16. doi: 10.1016/j.clinthera.2015.03.016. Epub 2015 Apr 20.

20.

Imaging preoperatively for pancreatic adenocarcinoma.

Pietryga JA, Morgan DE.

J Gastrointest Oncol. 2015 Aug;6(4):343-57. doi: 10.3978/j.issn.2078-6891.2015.024. Review.

Supplemental Content

Support Center